Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells

Biochem Biophys Res Commun. 1999 Mar 24;256(3):631-6. doi: 10.1006/bbrc.1999.0388.

Abstract

Sialoglycans on the cell surface of human colon cancer (HCC) cells have been implicated in cellular adhesion and metastasis. To clarify the role of N-acetylneuraminic acid (NeuAc) linked alpha2,3 to galactose (Gal) on the surface of HCC cells, we studied the intercellular adhesion of HCC cell lines expressing increasing NeuAcalpha2,3Gal-R. Our model system consisted of the HCC SW48 cell line, which inherently possesses low levels of cell surface alpha2,3 and alpha2,6 sialoglycans. To generate SW48 clonal variants with elevated cell surface NeuAcalpha2,3Gal-R linkages, we transfected the expression vector, pcDNA3, containing either rat liver cDNA encoding Galbeta1,3(4)GlcNAc alpha2,3 sialyltransferase (ST3Gal III) or human placental cDNA encoding Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3 sialyltransferase (ST3Gal IV) into SW48 cells. Selection of neomycin-resistant clones (600 microgram G418/ml) having a higher percentage of cells expressing NeuAcalpha2,3Gal-R (up to 85% positive Maackia amurenis agglutinin staining compared with 30% for wild type cells) was performed. These ST3Gal III and ST3Gal IV clonal variants demonstrated increased adherence to IL-1beta-activated human umbilical vein endothelial cells (HUVEC) (up to 90% adherent cells compared with 63% for wild type cells). Interestingly, ST3Gal III and ST3Gal IV clonal variants also bound non-activated HUVEC up to 4-fold more effectively than wild type cells. Cell surface NeuAcalpha2,3Gal-R expression within the various SW48 clonal variants correlated directly with increased adhesion to HUVEC (r=0.84). Using HCC HT-29 cells, which express high levels of surface NeuAcalpha2,3Gal-R, addition of synthetic sialyl, sulfo or GalNAc Lewis X structures were found to specifically inhibit intercellular adhesion. At 1.0mM, NeuAcalpha2,3Galbeta1,3(Fucalpha1, 4)GlcNAc-OH and Galbeta1,4(Fucalpha1,3)GlcNAcbeta1,6(SE-6Galbeta1++ +, 3)GalNAcalpha1-O-methyl inhibited HT-29 cell adhesion to IL-1beta-stimulated HUVEC by 100% and 68%, respectively. GalNAcbeta1, 4(Fucalpha1,3)GlcNAcbeta1-O-methyl and GalNAcbeta1,4(Fucalpha1, 3)GlcNAcbeta1,6Manalpha1,6Manbeta1-0-C30H61, however, did not possess inhibitory activity. In conclusion, these studies demonstrated that cell surface NeuAcalpha2,3Gal-R expression is involved in HCC cellular adhesion to HUVEC. These specific carbohydrate-mediated intercellular adhesive events may play an important role in tumor angiogenesis, metastasis and growth control.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Agglutinins / metabolism
  • Animals
  • Antibodies / pharmacology
  • Cell Adhesion* / drug effects
  • Clone Cells
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology*
  • E-Selectin / immunology
  • E-Selectin / physiology
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Flow Cytometry
  • Galactosides / metabolism*
  • Humans
  • Interleukin-1 / pharmacology
  • N-Acetylneuraminic Acid / analogs & derivatives
  • N-Acetylneuraminic Acid / metabolism*
  • Oligosaccharides / pharmacology
  • Rats
  • Receptors, Cell Surface / metabolism*
  • Sialyltransferases / genetics
  • Sialyltransferases / metabolism
  • Transfection
  • Tumor Cells, Cultured
  • Umbilical Veins
  • beta-Galactoside alpha-2,3-Sialyltransferase

Substances

  • Agglutinins
  • Antibodies
  • E-Selectin
  • Galactosides
  • Interleukin-1
  • Oligosaccharides
  • Receptors, Cell Surface
  • Sialyltransferases
  • N-Acetylneuraminic Acid
  • beta-Galactoside alpha-2,3-Sialyltransferase